Yu Hu Selected Research

RNA (Ribonucleic Acid)

2/2024	Targeting autophagy overcomes cancer-intrinsic resistance to CAR-T immunotherapy in B-cell malignancies.
8/2023	Immunosuppressive tumor microenvironment contributes to tumor progression in diffuse large B-cell lymphoma upon anti-CD19 chimeric antigen receptor T therapy.
6/2023	Targeting Trop2 by Bruceine D suppresses breast cancer metastasis by blocking Trop2/β-catenin positive feedback loop.
6/2023	Integration single-cell and bulk RNA-sequencing data to reveal senescence gene expression profiles in heart failure.
5/2023	Cuproptosis-related lncRNAs forecast the prognosis of acute myeloid leukemia.
3/2023	PAM-free cascaded strand displacement coupled with CRISPR-Cas12a for amplified electrochemical detection of SARS-CoV-2 RNA.
1/2023	IL-33-mediated activation of mast cells is involved in the progression of imiquimod-induced psoriasis-like dermatitis.
1/2022	Circular Ribonucleic Acid Expression Alteration in the Spinal Cord Tissue after Spinal Cord Injury in Rats.
1/2022	Integration of RNA molecules data with prior-knowledge driven Joint Deep Semi-Negative Matrix Factorization for heart failure study.
1/2022	FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m6A-YTHDF2-dependent manner.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu Hu Research Topics

Disease

194	Neoplasms (Cancer) 04/2024 - 02/2006
58	Multiple Myeloma 12/2024 - 02/2005
46	COVID-19 11/2023 - 01/2020
39	Inflammation (Inflammations) 04/2024 - 07/2006
29	Thrombosis (Thrombus) 10/2023 - 09/2004
25	Hematologic Neoplasms (Hematological Malignancy) 04/2024 - 05/2012
21	Infections 03/2024 - 12/2008
21	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 02/2024 - 01/2011
19	Hemorrhage 02/2024 - 01/2002
16	Neoplasm Metastasis (Metastasis) 04/2024 - 12/2009
15	Breast Neoplasms (Breast Cancer) 04/2024 - 12/2018
14	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 09/2009
14	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2023 - 02/2007
13	Disease Progression 01/2024 - 05/2010
12	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 01/2015
12	Atherosclerosis 01/2024 - 10/2008
11	Carcinogenesis 12/2023 - 07/2006
11	Thrombocytopenia (Thrombopenia) 12/2023 - 01/2012
10	Lymphoma (Lymphomas) 04/2024 - 11/2018
10	Leukemia 05/2023 - 02/2003
10	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2023 - 07/2012
10	Measles 01/2021 - 12/2011
9	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2024 - 01/2004
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2023 - 04/2014
8	Cytokine Release Syndrome 04/2024 - 01/2018
8	Cardiovascular Diseases (Cardiovascular Disease) 02/2023 - 09/2004
8	Insulin Resistance 01/2023 - 10/2015
8	Glioma (Gliomas) 09/2022 - 12/2013
8	Venous Thrombosis (Deep-Vein Thrombosis) 01/2018 - 01/2009
7	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2024 - 10/2016
7	Cognitive Dysfunction 01/2023 - 01/2015
7	Poliomyelitis (Polio) 12/2022 - 05/2014
7	Colorectal Neoplasms (Colorectal Cancer) 09/2022 - 06/2007
7	Pituitary Neoplasms (Pituitary Adenoma) 07/2021 - 11/2017
7	Disseminated Intravascular Coagulation 01/2021 - 01/2017
6	Sepsis (Septicemia) 12/2023 - 02/2013
6	Hyperglycemia 11/2023 - 04/2015
6	Fibrosis (Cirrhosis) 11/2023 - 01/2006
6	Venous Thromboembolism 08/2023 - 09/2017
6	Hypoxia (Hypoxemia) 01/2023 - 10/2015
6	Osteoporosis 01/2023 - 02/2016
6	Coronary Disease (Coronary Heart Disease) 12/2022 - 03/2003
6	Carcinoma (Carcinomatosis) 12/2019 - 01/2006
5	Triple Negative Breast Neoplasms 04/2024 - 01/2018
5	Wounds and Injuries (Trauma) 02/2024 - 01/2006
5	B-Cell Lymphoma (Lymphoma, B Cell) 02/2024 - 01/2020
5	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2023 - 05/2012

Drug/Important Bio-Agent (IBA)

50	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2005
41	Biomarkers (Surrogate Marker)IBA 12/2024 - 08/2008
26	MicroRNAs (MicroRNA)IBA 04/2024 - 05/2012
25	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2017 - 02/2005
23	Chimeric Antigen ReceptorsIBA 04/2024 - 07/2019
23	Therapeutic UsesIBA 01/2024 - 01/2015
22	RNA (Ribonucleic Acid)IBA 02/2024 - 02/2015
20	VaccinesIBA 10/2023 - 12/2011
19	Inosine Triphosphate (ITP)IBA 02/2024 - 01/2011
18	CytokinesIBA 04/2024 - 01/2005
18	Long Noncoding RNAIBA 01/2024 - 01/2018
17	Thromboplastin (Tissue Factor)IBA 01/2020 - 03/2003
16	Interleukin-6 (Interleukin 6)IBA 04/2024 - 01/2005
16	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 03/2014
15	LipidsIBA 09/2023 - 01/2005
13	fibrin fragment D (D-dimer)IBA 12/2023 - 01/2017
12	Messenger RNA (mRNA)IBA 10/2023 - 01/2002
12	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2023 - 02/2005
12	AntigensIBA 01/2023 - 02/2003
11	Small Interfering RNA (siRNA)IBA 04/2024 - 09/2007
11	AntibodiesIBA 10/2023 - 10/2007
10	Paclitaxel (Taxol)FDA LinkGeneric 01/2018 - 12/2013
9	InflammasomesIBA 12/2023 - 12/2010
9	Dacarbazine (DIC)FDA LinkGeneric 01/2021 - 01/2015
8	Monoclonal AntibodiesIBA 10/2023 - 10/2007
8	Rituximab (Mabthera)FDA Link 01/2023 - 04/2014
8	Imatinib Mesylate (Gleevec)FDA Link 01/2021 - 01/2009
7	AlbuminsIBA 03/2024 - 10/2018
7	Interleukin-17 (Interleukin 17)IBA 02/2024 - 08/2011
7	Tyrosine Kinase InhibitorsIBA 01/2023 - 04/2015
7	Oxygen (Dioxygen)IBA 01/2023 - 01/2016
6	AntioxidantsIBA 03/2024 - 04/2015
6	Blood Glucose (Blood Sugar)IBA 03/2024 - 07/2018
6	oxidized low density lipoproteinIBA 01/2024 - 01/2016
6	AnticoagulantsIBA 06/2023 - 11/2015
6	FibrinIBA 01/2023 - 01/2016
6	Insulin (Novolin)FDA Link 03/2022 - 11/2018
6	Fibrinogen (Factor I)FDA Link 01/2022 - 04/2002
6	Alanine Transaminase (SGPT)IBA 01/2022 - 10/2015
6	ORALIT (ORS)IBA 01/2021 - 01/2018
6	EnzymesIBA 10/2020 - 02/2006
5	Eosine Yellowish-(YS) (Eosin)IBA 04/2024 - 10/2018
5	Hematoxylin (Haematoxylon)IBA 04/2024 - 10/2018
5	ChemokinesIBA 03/2024 - 01/2018
5	Transcription Factors (Transcription Factor)IBA 02/2024 - 07/2006
5	CreatinineIBA 12/2023 - 10/2018

Therapy/Procedure

107	Therapeutics 04/2024 - 01/2002
29	Drug Therapy (Chemotherapy) 12/2023 - 02/2008
21	Immunotherapy 04/2024 - 09/2013
17	Hematopoietic Stem Cell Transplantation 01/2024 - 08/2015
8	Radiotherapy 05/2023 - 01/2012
6	Transplantation 01/2024 - 06/2017
5	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2023 - 01/2021